Immunoprecipitation of whole-cell lysates with an antiserum against SMYD3 or MET, followed by immunoblotting, indicated that SMYD3 is a molecular interactor of MET in CRC cells (Figs. 3C, 4). Here, SMYD3 is linked to colorectal carcinoma.